Cargando…
Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS)
SUMMARY: We investigated the association between bisphosphonate and denosumab use and risk of hip fracture in Norway. These drugs protect against fractures in clinical trials, but their population-level effect is unknown. Our results showed lowered risk of hip fracture for treated women. Treatment o...
Autores principales: | Riska, Brit Solvor Lyse, Gunnes, Nina, Stigum, Hein, Finnes, Trine E., Meyer, Haakon E., Omsland, Tone K., Holvik, Kristin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382386/ https://www.ncbi.nlm.nih.gov/pubmed/37100950 http://dx.doi.org/10.1007/s00198-023-06752-4 |
Ejemplares similares
-
The Association of Cold Ambient Temperature With Fracture Risk and Mortality: National Data From Norway—A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) Study
por: Dahl, Cecilie, et al.
Publicado: (2022) -
Cause-specific excess mortality after hip fracture: the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS)
por: Holvik, Kristin, et al.
Publicado: (2023) -
Correction to: Cause-specific excess mortality after hip fracture: the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS)
por: Holvik, Kristin, et al.
Publicado: (2023) -
Urban–Rural Differences in Hip Fracture Mortality: A Nationwide NOREPOS Study
por: Solbakken, Siri M, et al.
Publicado: (2019) -
Contribution of an extensive medication-based comorbidity index (Rx-Risk) in explaining the excess mortality after hip fracture in older Norwegians: a NOREPOS cohort study
por: Holvik, Kristin, et al.
Publicado: (2022)